Toxoplasma gondii merozoite gene expression analysis with comparison to the life cycle discloses a unique expression state during enteric development

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Behnke, Michael S ^a   Zhang, Tiange P ^a   Dubey, Jitender P ^b   Sibley, L D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Definitive host; Enteric stages; Gene expression; Life cycle; Merozoite; Parasite; Toxoplasma gondii

Indexed keywords

ARTICLE; CONTROLLED STUDY; DHFR GENE; DOWN REGULATION; ENOLASE 2 GENE; FATTY ACID SYNTHESIS; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLYCOLYSIS; LDH1 GENE; MEROZOITE; NONHUMAN; PROMOTER REGION; PYRIMIDINE SYNTHESIS; RNA TRANSLATION; SRS22B GENE; SRS22H GENE; TGME49 GENE; TOXOPLASMA GONDII; UPREGULATION; ANIMAL; CAT; CLUSTER ANALYSIS; DNA MICROARRAY; GENETICS; METABOLISM; PARASITOLOGY; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; TOXOPLASMA; TOXOPLASMOSIS;

COCCIDIA; FELIDAE; TOXOPLASMA; TOXOPLASMA GONDII;

MESSENGER RNA; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ANIMALS; ANTIGENS, PROTOZOAN; CATS; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; MEROZOITES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PROMOTER REGIONS, GENETIC; PROTOZOAN PROTEINS; RNA, MESSENGER; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 84900865946     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-350     Document Type: Article

References (58)

1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004, 363(9425):1965-1976. 10.1016/S0140-6736(04)16412-X, 15194258.
2. Jones JL, Roberts JM. Toxoplasmosis hospitalizations in the United States, 2008, and trends, 1993-2008. Clin Infect Dis 2012, 54(7):e58-e61. 10.1093/cid/cir990, 22267718.
3. Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 2009, 49(6):878-884. 10.1086/605433, 19663709.
4. Jones JL, Holland GN. Annual burden of ocular toxoplasmosis in the US. Am J Trop Med Hyg 2010, 82(3):464-465. 10.4269/ajtmh.2010.09-0664, 2829910, 20207874.
5. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17(1):7-15. 10.3201/eid1701.P11101, 3375761, 21192848.
6. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg 2007, 77(3):405-410.
7. Dubey JP. History of the discovery of the life cycle of Toxoplasma gondii. Int J Parasitol 2009, 39(8):877-882. 10.1016/j.ijpara.2009.01.005, 19630138.
8. Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 2005, 6(1):41-61. 10.1079/AHR2005100, 16164008.
9. Su C, Evans D, Cole RH, Kissinger JC, Ajioka JW, Sibley LD. Recent expansion of Toxoplasma through enhanced oral transmission. Science 2003, 299:414-416. 10.1126/science.1078035, 12532022.
10. Dubey JP. Toxoplasma, Hammondia, Besniotia, Sarcocystis, and Other Tissue Cyst-forming Coccidia of Man and Animals. Parasitic Protozoa 1977, 101-237. New York: Academic Press, Kreier JP.
11. Dubey JP. The history of Toxoplasma gondii-the first 100 years. J Eukaryot Microbiol 2008, 55(6):467-475. 10.1111/j.1550-7408.2008.00345.x, 19120791.
12. Hogan MJ, Yoneda C, Feeney L, Zweigart P, Lewis A. Morphology and culture of Toxoplasma. Trans Am Ophthalmol Soc 1960, 58:167-187. 1316370, 13715142.
13. Matsubayashi H, Akao S. Morphological studies on the development of the Toxoplasma cyst. Am J Trop Med Hyg 1963, 12:321-333.
14. Weiss LM, Laplace D, Takvorian PM, Tanowitz HB, Cali A, Wittner M. A cell culture system for study of the development of Toxoplasma gondii bradyzoites. J Eukaryot Microbiol 1995, 42(2):150-157. 10.1111/j.1550-7408.1995.tb01556.x, 7757057.
15. Soete M, Camus D, Dubremetz JF. Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. Exp Parasitol 1994, 78(4):361-370. 10.1006/expr.1994.1039, 8206135.
16. Sibley LD. Invasion and intracellular survival by protozoan parasites. Immunol Rev 2011, 240(1):72-91. 10.1111/j.1600-065X.2010.00990.x, 3697736, 21349087.
17. Boyle JP, Radke JR. A history of studies that examine the interactions of Toxoplasma with its host cell: Emphasis on in vitro models. Int J Parasitol 2009, 39(8):903-914. 10.1016/j.ijpara.2009.01.008, 19630139.
18. Hunter CA, Sibley LD. Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat Rev Microbiol 2012, 10(11):766-778. 10.1038/nrmicro2858, 3689224, 23070557.
19. Dubey JP, Frenkel JK. Cyst-induced toxoplasmosis in cats. J Protozool 1972, 19(1):155-177. 10.1111/j.1550-7408.1972.tb03431.x, 5008846.
20. Ferguson DJ. Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host. Int J Parasitol 2004, 34(3):347-360. 10.1016/j.ijpara.2003.11.024, 15003495.
21. Ferguson DJ, Hutchison WM, Dunachie JF, Siim JC. Ultrastructural study of early stages of asexual multiplication and microgametogony of Toxoplasma gondii in the small intestine of the cat. Acta Pathol Microbiol Scand B: Microbiol Immunol 1974, 82(2):167-181.
22. Speer CA, Dubey JP. Ultrastructural differentiation of Toxoplasma gondii schizonts (types B to E) and gamonts in the intestines of cats fed bradyzoites. Int J Parasitol 2005, 35(2):193-206. 10.1016/j.ijpara.2004.11.005, 15710440.
23. Omata Y, Taka A, Terada K, Koyama T, Kanda M, Saito A, Dubey JP. Isolation of coccidian enteroepithelial stages of Toxoplasma gondii from the intestinal mucosa of cats by Percoll density-gradient centrifugation. Parasitol Res 1997, 83(6):574-577. 10.1007/s004360050300, 9211509.
24. Taka A, Omata Y, Ohsawa T, Koyama T, Kanda M, Saito A, Toyoda Y. Antibody reactivity in mice and cats to feline enteroepithelial stages of Toxoplasma gondii. Vet Parasitol 1999, 83(1):73-78. 10.1016/S0304-4017(99)00023-0, 10392770.
25. Dubey JP, Passos LM, Rajendran C, Ferreira LR, Gennari SM, Su C. Isolation of viable Toxoplasma gondii from feral guinea fowl (Numida meleagris) and domestic rabbits (Oryctolagus cuniculus) from Brazil. J Parasitol 2011, 97(5):842-845. 10.1645/GE-2728.1, 21506805.
26. Bahl A, Davis PH, Behnke M, Dzierszinski F, Jagalur M, Chen F, Shanmugam D, White MW, Kulp D, Roos DS. A novel multifunctional oligonucleotide microarray for Toxoplasma gondii. BMC Genomics 2010, 11:603. 10.1186/1471-2164-11-603, 3017859, 20974003.
27. Fritz HM, Buchholz KR, Chen X, Durbin-Johnson B, Rocke DM, Conrad PA, Boothroyd JC. Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. PLoS One 2012, 7(2):e29998. 10.1371/journal.pone.0029998, 3278417, 22347997.
28. Behnke MS, Radke JB, Smith AT, Sullivan WJ, White MW. The transcription of bradyzoite genes in Toxoplasma gondii is controlled by autonomous promoter elements. Mol Microbiol 2008, 68(6):1502-1518. 10.1111/j.1365-2958.2008.06249.x, 2440561, 18433450.
29. Cleary MD, Singh U, Blader IJ, Brewer JL, Boothroyd JC. Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expression. Eukaryot Cell 2002, 1(3):329-340. 10.1128/EC.1.3.329-340.2002, 118016, 12455982.
30. Radke JR, Behnke MS, Mackey AJ, Radke JB, Roos DS, White MW. The transcriptome of Toxoplasma gondii. BMC Biol 2005, 3:26. 10.1186/1741-7007-3-26, 1325263, 16324218.
31. Samuelson J, Bushkin GG, Chatterjee A, Robbins PW. Strategies to discover the structural components of cyst and oocyst walls. Eukaryot Cell 2013, 12(12):1578-1587. 10.1128/EC.00213-13, 24096907.
32. Braun L, Brenier-Pinchart MP, Yogavel M, Curt-Varesano A, Curt-Bertini RL, Hussain T, Kieffer-Jaquinod S, Coute Y, Pelloux H, Tardieux I, Sharma A, Belrhali H, Bougdour A, Hakimi MA. A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation. J Exp Med 2013, 210(10):2071-2086. 10.1084/jem.20130103, 3782045, 24043761.
33. Carruthers VB, Tomley FM. Microneme proteins in apicomplexans. Subcell Biochem 2008, 47:33-45. 10.1007/978-0-387-78267-6_2, 2847500, 18512339.
34. Wasmuth JD, Pszenny V, Haile S, Jansen EM, Gast AT, Sher A, Boyle JP, Boulanger MJ, Parkinson J, Grigg ME. Integrated bioinformatic and targeted deletion analyses of the SRS gene superfamily identify SRS29C as a negative regulator of Toxoplasma virulence. MBio 2012, 3(6):e00321-e00312. 3509429, 23149485.
35. Behnke MS, Wootton JC, Lehmann MM, Radke JB, Lucas O, Nawas J, Sibley LD, White MW. Coordinated progression through two subtranscriptomes underlies the tachyzoite cycle of Toxoplasma gondii. PLoS One 2010, 5(8):e12354. 10.1371/journal.pone.0012354, 2928733, 20865045.
36. Bozdech Z, Llinas M, Pulliam BL, Wong ED, Zhu J, DeRisi JL. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol 2003, 1(1):E5. 176545, 12929205.
37. Radke JR, Gubbels MJ, Jerome ME, Radke JB, Striepen B, White MW. Identification of a sporozoite-specific member of the Toxoplasma SAG superfamily via genetic complementation. Mol Microbiol 2004, 52(1):93-105. 10.1111/j.1365-2958.2003.03967.x, 15049813.
38. Bohne W, Wirsing A, Gross U. Bradyzoite-specific gene expression in Toxoplasma gondii requires minimal genomic elements. Mol Biochem Parasitol 1997, 85(1):89-98. 10.1016/S0166-6851(96)02814-9, 9108551.
39. Nakaar V, Bermudes D, Peck KR, Joiner KA. Upstream elements required for expression of nucleoside triphosphate hydrolase genes of Toxoplasma gondii. Mol Biochem Parasitol 1998, 92(2):229-239. 10.1016/S0166-6851(97)00220-X, 9657328.
40. Soldati D, Boothroyd JC. Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii. Science 1993, 260(5106):349-352. 10.1126/science.8469986, 8469986.
41. Elemento O, Slonim N, Tavazoie S. A universal framework for regulatory element discovery across all genomes and data types. Mol Cell 2007, 28(2):337-350. 10.1016/j.molcel.2007.09.027, 2900317, 17964271.
42. Van Poppel NF, Welagen J, Vermeulen AN, Schaap D. The complete set of Toxoplasma gondii ribosomal protein genes contains two conserved promoter elements. Parasitology 2006, 133(Pt 1):19-31.
43. Walker R, Gissot M, Huot L, Alayi TD, Hot D, Marot G, Schaeffer-Reiss C, Van Dorsselaer A, Kim K, Tomavo S. Toxoplasma transcription factor TgAP2XI-5 regulates the expression of genes involved in parasite virulence and host invasion. J Biol Chem 2013, 288(43):31127-31138. 10.1074/jbc.M113.486589, 24025328.
44. Goodswen SJ, Kennedy PJ, Ellis JT. A review of the infection, genetics, and evolution of Neospora caninum: from the past to the present. Infect Genet Evol 2013, 13:133-150.
45. David Sibley L. Recent origins among ancient parasites. Vet Parasitol 2003, 115(2):185-198. 10.1016/S0304-4017(03)00206-1, 12878422.
46. Piekarski G, Pelster B, Witte HM. Endopolygeny in Toxoplasma gondii. Z Parasitenkd 1971, 36(2):122-130.
47. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011, 11(2):85-95. 10.1038/nrc2981, 21258394.
48. Colgan SP, Taylor CT. Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 2010, 7(5):281-287. 10.1038/nrgastro.2010.39, 20368740.
49. Radke JB, Lucas O, De Silva EK, Ma Y, Sullivan WJ, Weiss LM, Llinas M, White MW. ApiAP2 transcription factor restricts development of the Toxoplasma tissue cyst. Proc Natl Acad Sci U S A 2013, 110(17):6871-6876. 10.1073/pnas.1300059110, 3637731, 23572590.
50. Baker DA. Malaria gametocytogenesis. Mol Biochem Parasitol 2010, 172(2):57-65. 10.1016/j.molbiopara.2010.03.019, 2880792, 20381542.
51. Muller J, Hemphill A. In vitro culture systems for the study of apicomplexan parasites in farm animals. Int J Parasitol 2013, 43(2):115-124. 10.1016/j.ijpara.2012.08.004, 23000674.
52. Kolev NG, Ramey-Butler K, Cross GA, Ullu E, Tschudi C. Developmental progression to infectivity in Trypanosoma brucei triggered by an RNA-binding protein. Science 2012, 338(6112):1352-1353. 10.1126/science.1229641, 3664091, 23224556.
53. Behnke MS, Khan A, Wootton JC, Dubey JP, Tang K, Sibley LD. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci U S A 2011, 108(23):9631-9636. 10.1073/pnas.1015338108, 3111276, 21586633.
54. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20(3):307-315. 10.1093/bioinformatics/btg405, 14960456.
55. Gajria B, Bahl A, Brestelli J, Dommer J, Fischer S, Gao X, Heiges M, Iodice J, Kissinger JC, Mackey AJ, Pinney DF, Roos DS, Stoeckert CJ, Wang H, Brunk BP. ToxoDB: an integrated Toxoplasma gondii database resource. Nucleic Acids Res 2008, 36(Database issue):D553-D556. 2238934, 18003657.
56. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012, 40(Database issue):D109-D114. 3245020, 22080510.
57. Messina M, Niesman I, Mercier C, Sibley LD. Stable DNA transformation of Toxoplasma gondii using phleomycin selection. Gene 1995, 165(2):213-217. 10.1016/0378-1119(95)00548-K, 8522178.
58. Sibley LD, Khan A, Ajioka JW, Rosenthal BM. Genetic diversity of Toxoplasma gondii in animals and humans. Philos Trans R Soc Lond B Biol Sci 2009, 364(1530):2749-2761. 10.1098/rstb.2009.0087, 2865090, 19687043.